Elinore F McCance-Katz
Affiliation: University of California
- Untreated HIV infection is associated with higher blood alcohol levelsElinore F McCance-Katz
Department of Psychiatry, Addiction Medicine Research, University of California San Francisco, San Francisco, CA, USA
J Acquir Immune Defic Syndr 60:282-8. 2012..This pilot study examines the relationship of untreated HIV infection to blood alcohol concentrations (BAC) relative to BAC after initiation of antiretroviral therapy (ART)...
- Rifampin, but not rifabutin, may produce opiate withdrawal in buprenorphine-maintained patientsElinore F McCance-Katz
University of California San Francisco, San Francisco, CA 94110, USA
Drug Alcohol Depend 118:326-34. 2011....
- Drug interactions associated with methadone, buprenorphine, cocaine, and HIV medications: implications for pregnant womenElinore F McCance-Katz
Department of Psychiatry, University of California San Francisco, San Francisco General Hospital, United States
Life Sci 88:953-8. 2011....
- Effect of cocaine use on methadone pharmacokinetics in humansElinore F McCance-Katz
Department of Psychiatry, University of California San Francisco, San Francisco, California, USA
Am J Addict 19:47-52. 2010..09) and more rapid methadone clearance (p = .08). Regular cocaine use may adversely impact treatment outcomes for opioid dependence in those receiving methadone maintenance by decreasing methadone exposure...
- Effect of cocaine use on buprenorphine pharmacokinetics in humansElinore F McCance-Katz
Department of Psychiatry, University of California San Francisco, San Francisco, California, USA
Am J Addict 19:38-46. 2010..Regular cocaine users were younger (p = .0007), and used more heroin (p = .004) and cocaine (p < .0001). Regular cocaine use may result in lower buprenorphine plasma concentrations with potential for adverse clinical outcomes...
- Lack of clinically significant drug interactions between nevirapine and buprenorphineElinore F McCance-Katz
Department of Psychiatry, University of California, San Francisco, California, USA
Am J Addict 19:30-7. 2010..Buprenorphine did not alter nevirapine pharmacokinetics. Dose adjustments of either buprenorphine or nevirapine are not likely to be necessary when these drugs are coadministered for the treatment of opiate dependence and HIV disease...
- Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a reviewElinore F McCance-Katz
Department of Psychiatry, University of California, San Francisco, San Francisco, California, USA
Am J Addict 19:4-16. 2010..A substantial literature has accumulated on drug interactions between either methadone or buprenorphine with other medications when ingested concomitantly by humans. This review summarizes current literature in this area...
- Methadone, buprenorphine, and street drug interactions with antiretroviral medicationsValerie A Gruber
San Francisco General Hospital, University of California San Francisco, 1001 Potrero Avenue, Ward 93 95, San Francisco, CA 94110, USA
Curr HIV/AIDS Rep 7:152-60. 2010..Further, there are many frequently used medications in treatment of complications of HIV disease that have not been studied. There is need for continuing research to define these drug interactions and their clinical significance...
- Interactions between buprenorphine and the protease inhibitors darunavir-ritonavir and fosamprenavir-ritonavirValerie A Gruber
Department of Psychiatry, University of California San Francisco, CA, USA
Clin Infect Dis 54:414-23. 2012..This study examined drug interactions between buprenorphine, a partial opioid agonist used for opioid dependence treatment and pain management, and the protease inhibitors (PIs) darunavir-ritonavir and fosamprenavir-ritonavir...
- Interactions between buprenorphine and antiretrovirals: nucleos(t)ide reverse transcriptase inhibitors (NRTI) didanosine, lamivudine, and tenofovirJennifer Baker
Department of Psychiatry, Virginia Commonwealth University, Richmond, Virginia, USA
Am J Addict 19:17-29. 2010..Buprenorphine had no significant effect on NRTI concentrations. Concomitant use of buprenorphine with ddI, 3TC, or TDF results in neither a significant pharmacokinetic nor pharmacodynamic interaction...
- Interactions between alcohol and the HIV entry inhibitor MaravirocValerie A Gruber
Department of Psychiatry, University of California San Francisco, San Francisco, CA, USA
J Int Assoc Provid AIDS Care 12:375-7. 2013..The present study evaluated the effects of alcohol on maraviroc pharmacokinetics and the effects of maraviroc on alcohol pharmacokinetics...
- Office-based buprenorphine treatment for opioid-dependent patientsElinore F McCance-Katz
Division of Addiction Psychiatry, Department of Psychiatry, Virginia Commonwealth University, VA, USA
Harv Rev Psychiatry 12:321-38. 2004....
- Interaction of disulfiram with antiretroviral medications: efavirenz increases while atazanavir decreases disulfiram effect on enzymes of alcohol metabolismElinore F McCance-Katz
University of California San Francisco, San Francisco, California
Am J Addict 23:137-44. 2014..Alcohol pharmacotherapies, including disulfiram (DIS), are infrequently utilized in co-occurring HIV and alcohol use disorders possibly related to concerns about drug interactions between antiretroviral (ARV) medications and DIS...
- Team-based learning exercise efficiently teaches brief intervention skills to medicine residentsMaria A Wamsley
a Division of General Internal Medicine, University of California, San Francisco, San Francisco, California, USA
Subst Abus 34:344-9. 2013..This study examined whether a 3-hour SBI curriculum for internal medicine residents utilizing a team-based learning (TBL) format is effective for SBI skills as measured by a standardized patient (SP) assessment...
- Adapting Screening, Brief Intervention, and Referral to Treatment for Alcohol and Drugs to Culturally Diverse Clinical PopulationsJennifer K Manuel
San Francisco Veterans Affairs Medical Center JKM, San Francisco, CA Department of Psychiatry DDS, JT, JSR, University of California, San Francisco, CA Division of Research DDS, Kaiser Permanente Northern California Region, Oakland, CA Division of General Internal Medicine GM J, JMS, Department of Medicine, University of California, San Francisco, CA and Substance Abuse and Mental Health Services Administration EFM K, Rockville, MD
J Addict Med 9:343-51. 2015....
- Effects of HCV seropositive status on buprenorphine pharmacokinetics in opioid-dependent individualsCarmen L Masson
Department of Psychiatry, University of California, San Francisco, California
Am J Addict 23:34-40. 2014..The purpose of this study was to examine the effect of hepatitis C virus (HCV) infection on buprenorphine pharmacokinetics in opioid-dependent, buprenorphine/naloxone-maintained adults...
- Integrating screening, brief intervention, and referral to treatment (SBIRT) into clinical practice settings: a brief reviewSuneel M Agerwala
University of California, San Francisco, Addiction Medicine Research, Department of Psychiatry, San Francisco, CA, USA
J Psychoactive Drugs 44:307-17. 2012..Screening large numbers of individuals presents an opportunity to engage those who are in need of treatment. However, additional research is needed to determine how best to implement SBIRT...
- A primary care approach to substance misuseBrad Shapiro
University of California, San Francisco, School of Medicine, San Francisco, CA, USA
Am Fam Physician 88:113-21. 2013..The use of a motivational rather than a confrontational communication style during screening, counseling, and treatment is important to improve patient outcomes. ..
- Using standardized patients to evaluate screening, brief intervention, and referral to treatment (SBIRT) knowledge and skill acquisition for internal medicine residentsJason M Satterfield
Division of General Internal Medicine, University of California San Francisco, San Francisco, California 94143, USA
Subst Abus 33:303-7. 2012..Residents made moderate improvements in brief intervention skills. Future SBIRT curricular evaluations would ideally include a controlled comparison with larger samples from multiple institutions...
- Efficacy of dose and contingency management procedures in LAAM-maintained cocaine-dependent patientsAlison Oliveto
Department of Psychiatry, Yale School of Medicine and the VA CT Healthcare System, West Haven, CT, USA
Drug Alcohol Depend 79:157-65. 2005..These results suggest that an efficacious maintenance dose is necessary for contingencies to be effective in facilitating both opioid and cocaine abstinence...
- COCAINE, ALCOHOL, AND COCAETHYLENE--CLINICAL EFFECTSElinore McCance Katz; Fiscal Year: 2002..In total, these studies should provide significant contributions to the current state of knowledge regarding the epidemiology of cocaine-alcohol abuse and treatment of these disorders. ..
- COCAETHYLENE COCAINE AGONIST THERAPY/TOLERANCE INDUCTIONElinore McCance Katz; Fiscal Year: 2002..Positive findings from these studies could be followed in future studies with clinical trials to assess the efficacy of this class of drugs in the treatment of cocaine dependence. ..
- Opioids & HIV Medications: Interactions in Drug AbusersElinore McCance Katz; Fiscal Year: 2008..Drug interaction studies of the type proposed have been identified as a priority research area for NIDA because of their importance to optimizing the clinical care of HIV disease in opioid dependent patients. ..
- Disulfiram Interactions With HIV Medications: Clinical ImplicationsElinore F McCance Katz; Fiscal Year: 2010....
- Interaction of Alcohol and HAART in HIV/AIDS and HIV/AIDS and HCV CoinfectionElinore F McCance Katz; Fiscal Year: 2011..The proposed studies will inform clinical treatment of comorbid HIV/AIDS, Hepatitis C and alcohol use/abuse leading to improved clinical outcomes and reduced risk of HIV transmission. ..